-
Research -
Patient Care -
Education -
People -
Shared Resources -
Cancer Data Science -
Cell & Tissue Imaging -
Epigenetics & Epigenomics -
Experimental Irradiation -
Flow Cytometry -
Health Communications -
Immune Monitoring -
Liquid Biopsy -
Pharmacokinetics -
Preclinical Molecular Imaging -
Protoemics Resource Facility -
Single Cell Spatial Analysis -
Structure & Drug Screening -
Tissue & Molecular Pathology -
Transgenic Animal Models
-
-
About -
Forbes Institute for Cancer Discovery
Clinical Research Division
Improving patient care
Our clinical research teams are the focal point for clinical trials that provide cutting edge treatment for patients at the University of Michigan Rogel Cancer Center. These teams of practicing clinicians work collaboratively with researchers across the cancer center to build a strong portfolio of clinical trials for our patients. We want to improve cancer care and create new and better treatments.
Clinical research teams are comprised of a range of experts in cancer research, including:
- Physicians from multiple disciplines (surgery, medicine, radiation oncology, pathology, neurology, radiology, gynecology)
- Translational cancer research scientists
- Advanced practice providers
- Nurses
- Geneticists
- Clinical research coordinators
- Data managers
- Regulatory specialists
- Patient advocates
Clinical Research Teams Across Many Cancer Types
Across a wide range of cancer types, our teams review and prioritize proposed clinical trials arising from Rogel Cancer Center members and national organizations to ensure scientific merit and increase the chances of successful implementation. Led by Associate Director Kyle Cuneo, MD, our clinical research enterprise includes the following specific clinical research teams:
- Biomarker Development and Validation
- Bone Marrow Transplant
- Breast Oncology
- Cancer Prevention and Survivorship
- Childhood Cancer
- Connective Tissue Oncology
- Cutaneous Oncology
- Gastrointestinal Oncology
- Genitourinary Oncology
- Gynecologic Oncology
- Head, Neck and Endocrine Oncology
- Hematologic Malignancies
- Multi-tumor Experimental Therapeutics
- Neurologic Oncology
- Thoracic Oncology
Support for Clinical Research Studies across all Rogel Cancer Center Programs
Our clinical research teams collaborate with researchers and research programs, fostering true bench-to-bedside and bedside-to-bench research. The clinical research teams provide perspective and support for the unique patient populations they represent. Although primarily focused on interventional cancer clinical trials, our clinical research portfolio also includes these types of studies:
- Ancillary
- Correlative
- Diagnostic
- Epidemiologic
- Observational
Support for Cancer Clinical Trials
We offer support and oversight for all cancer clinical trials at the University of Michigan through the following components:
- Clinical Protocol and Data Management: Provides central management and oversight functions for coordinating, facilitating and reporting on the cancer clinical trials at Rogel.
- Protocol Review and Monitoring System: Provides rigorous internal oversight of the scientific aspects of all cancer-related clinical research at the University of Michigan
- Data and Safety Monitoring Committee: Provides independent oversight for data and safety monitoring for cancer clinical trials that are not monitored by an external board
University of Michigan Health clinical researchers also have access to the O-CTSU website.
Ravitz Foundation Phase 1 / Translational Research Center
Our dedicated translational research unit, under the leadership of Ulka Vaishampayan, MBBS, is open to clinical trials for all types of cancer. Patients who volunteer to participate in Phase 1 clinical trials are seen in a centralized space with strict monitoring by faculty physicians, nurses trained in clinical research and data managers — all dedicated specifically to this research. The Phase 1 Unit, located on the cancer center's second floor, offers five chairs and one bed for infusion as well as facilities for specialized patient monitoring.
Our Team
Kyle C Cuneo, MD
Medical School
John M Magenau
Medical Director, Adult Bone Marrow Transplant
Medical School
Questions?
Contact Us
If you would like more information about the clinical research teams or programs at the Rogel Cancer Center, please contact one of our team members.
